Core Viewpoint - The collaboration between the company and Boji Pharmaceutical Technology Co., Ltd. marks a significant step in the company's strategic development in the innovative drug sector, focusing on the clinical research and registration of a new traditional Chinese medicine product [1] Group 1: Partnership Details - The company has signed a "Technical Entrustment (Development) Contract" with Boji Pharmaceutical, which will assist in completing the clinical research and registration of a Class 1 compound medicine [1] - This partnership is described as a strong alliance based on a shared development strategy, leveraging the strengths of both parties [1] Group 2: Advantages of Collaboration - Boji Pharmaceutical is recognized as an industry leader with significant advantages in research and development capabilities, technical accumulation, and clinical resources [1] - The collaboration is expected to create a synergistic effect, enhancing the research and development efficiency and success rate of the contracted product [1] - This partnership aims to lay a solid foundation for the subsequent application and market launch of the product [1]
小方制药(603207.SH)委托博济医药技术开发中药1.1类新药“复方侧柏酊”(脱发适应症)